The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I'm on my third box of Axisbiotix now and will conitnue using. I did break off for three weeks during a holiday and the Psoriasis flared up again. After just 5 days on the sachets it is almost invisible again. This is important for me as an investor having faith in the product. I suspect I can reduce the dose to every two days. which then makes a £20/mo cost reasonable and worth it for the alleviation of itching alone (I'm a bit of a miser!). I believe a working acne product will be far more valuable to the company though with a potential global customer base of 650 million. One percent of this would propel the value of the share. Croda may be just the icing on the cake or the cake itself (cosmetics not my area of expertise). Several other potential products makes this a no-brainer long term hold.
I'm 23 days into the first course of Avixbiotix and a Psoriasis patch on my leg has visibly improved and stopped itching. I will purchase another 28 days to see if it disappears completely. As the rollout to Europe continues a potential 15 million sufferers ( 2% of 750 Million) can benefit from this treatment. If only 2% of those purchase then 300K/day possible - £110M
revenue per year from just Europe. Add in the America's/Asia etc and this grows substantially on ONE product. There is still Croda, a dedicated ACNE product and some other areas to add in if they materialise. Does seem to be undervalued from my simplistic viewpoint.!
Received this in my email yesterday. High demand not translating into the share price!
We hope all of our customers are staying safe during these adverse weather conditions. Please note the couriers are experiencing understandable difficulties delivering parcels. Rest assured your products will arrive as soon as possible. Cholbiome X3 is currently out of stock due to very high demand and we are currently replacing these with Cholbiome BP for our subscription holders. These will keep your cholesterol low in the interim whilst we get more stock in Feb ‘23. We apologise for any inconvenience and appreciate your patience.
Apologies if already posted.
https://uk.trustpilot.com/review/axisbiotix.com
This appears to be one of rare occasions where the market fails to look forward. Not surprised at the lower than expected dividend (although still good by any measure). Seems wise with the government looking on closely. Interesting to see how this reacts after the analysts meeting.
Ordered the Cholbiome X3 (£24.69 delivered with 10% discount). Was going to pass to the GF but decided to take myself for a month and to see if it benefits me first...noble gesture I know.
I'm a mid fifties, slightly overweight non-athlete so bang on the target market. If I don't have any side-effects I'll order some for the GF. Try and keep her going for a few more years.
Hi Belgrano.
I probably should have said minimal risk. I'm a firm believer this will do very well over the next 3 years and could surprise a lot sooner but I've been caught out in the market before on what I believed were no-brainers so just conveying a little bit of caution.
Best regards DK
Another positive update about LPLDL.
I have been thinking about purchasing some Cholbiome X3 for my GF who has elevated cholesterol. If Elrico is about does he know if shareholders can still get a discount code? Thanks
According to Psoriasis.org there are 125 Million sufferers worldwide. If we picked up 1% of that at £1 per day profit each it would make SBTX a billion + market cap company at a very low P.E, ....assuming I've pressed the calculator keys in the right order.
I had Psoriasis myself from the age of 8 to about 30 with scaly, itchy patces on my knees, elbows and skull. I used coal tar ointment at the time, which had minimal effect and smelled rather pungent. I would through my teen years have happily paid to make myself slightly more attractive to the fairer sex and not be shedding skin everywhere. I had it fairly mild though, nothing like as bad as 'The singing detective' (remember that?). I really hope the Axisbiotix takes off and not just because I now have a vested interest in the company's fortunes.
I do think a potential acne cure would be even more important though - an estimated 650 million people worldwide. 0.1% of that business would be handy too.
And at the weekend my fair lady was pondering a £300 tube of anti-ageing cream! I talked her out of it of course but shows the potential in cosmetics.
Still a risky share and if it all goes wrong at least I can cuddle up to the wrinkly better half, or even the wife.
As announced in September 2020, the Company will likely only proceed with exploration if nearby adjacent drilling
de-risks the basin sufficiently to generate partnering.
• Non-cash impairments of US$66.7 million made in respect of Namibia and Brazil and US$0.5 million.
against remaining drilling inventory reflective of change in strategic direction and Management’s approach
to non-core assets in the current challenging market environment.
• Whilst fully written down, Chariot has retained its interest in Namibia and Brazil with no work commitments
going forward and will continue to host data-rooms for marketing of both assets.
An Acne treatment could be very beneficial to the company finances. I'd have spent most of my beer money on it in my teens if available then!
"Acne is estimated to affect 9.4% of the global population, making it the eighth most prevalent disease worldwide."
Ceres presenting teach on on SOEC (Solid Oxide Electrolysis Cell) tomorrow July 1st for analysts/investors.
Interesting article for background reading on SOEC's https://www.ammoniaenergy.org/articles/the-future-is-here-for-solid-oxide-electrolysis-cell-technology/
Sorry if posted before but good overview for any newbies. https://www.youtube.com/watch?v=GcVWcRCfwck
And a timely article about oral health and microbiomes in The Times today
Looking forward once this Covid-19 is cleared. I'd assume test strips would be useful for whatever prevailing Flu is coming along EVERY year. Would limit the spread of normal Influenza in hospitals, care homes and the workplace.
For me the Cancer and Chemotherapy related work is the most exciting though.
Just ordered some Slimbiome off H&B to try with the MSE code. More expensive than I'd normally pay for weight control products but I'm more interested in what this product does for my health than the shareprice (I'm a very small holder). I hope that the general public will feel the same way.
https://www.mirror.co.uk/tech/womens-femtech-health-gadgets-including-20374814
I bought these six months ago for three reasons and happy to see them moving north.
1. My local (The Spa in Weymouth) is a great pub with top notch landlord. If they are replicating this across the country then that is very good news.
2. The dividend is welcome when the share price eventually stagnates (maybe not for a while yet)
3. The priviledge card is worth having to save a few quid on meals and hotels.
A solid addition to my portfolio and expect some further rises over the next 6 months plus.
Positive article in the Times today ref US beer sales
Apparently (from advfn) Boots could be selling from later this week. If so would expect an uptick soon.